ATE71662T1 - Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. - Google Patents

Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.

Info

Publication number: ATE71662T1
Authority: AT; Austria
Prior art keywords: human; leukopaenia; treatment; pharmaceutical preparation; csf
Prior art date: 1985-10-04

Application number

AT86113671T

Other languages

English (en)

Inventor

Masahiko Tamura

Hitoshi Nomura

Kunihiro Hattori

Masayoshi Ono

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-04

Filing date

1986-10-03

Publication date

1992-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26462024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE71662(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1986-10-03 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1992-02-15 Application granted granted Critical

1992-02-15 Publication of ATE71662T1 publication Critical patent/ATE71662T1/de

Links

210000003714 granulocyte Anatomy 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 abstract 5
230000000694 effects Effects 0.000 abstract 2
201000002364 leukopenia Diseases 0.000 abstract 2
231100001022 leukopenia Toxicity 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000288 Glycoproteins Proteins 0.000 abstract 1
102000003886 Glycoproteins Human genes 0.000 abstract 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 1
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
238000002955 isolation Methods 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000006228 supernatant Substances 0.000 abstract 1
230000001131 transforming effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Hematology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

AT86113671T 1985-10-04 1986-10-03 Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. ATE71662T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP22045085		1985-10-04
JP61125660A JPH0618778B2 (ja)	1985-10-04	1986-06-02	白血球減少症治療剤
EP86113671A EP0217404B2 (de)	1985-10-04	1986-10-03	Einen menschlichen Granulozytkoloniereizfaktor für die Behandlung von Leukopenien enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number	Publication Date
ATE71662T1 true ATE71662T1 (de)	1992-02-15

Family

ID=26462024

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86113671T ATE71662T1 (de)	1985-10-04	1986-10-03	Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.

Country Status (11)

Country	Link
EP (1)	EP0217404B2 (de)
JP (1)	JPH0618778B2 (de)
KR (1)	KR960000394B1 (de)
AT (1)	ATE71662T1 (de)
AU (1)	AU596997C (de)
DE (1)	DE3683430D1 (de)
DK (1)	DK172204B1 (de)
ES (1)	ES2055684T5 (de)
FI (1)	FI863971L (de)
HK (1)	HK65693A (de)
NO (1)	NO863918L (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0764742B2 (ja) *	1985-11-27	1995-07-12	ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド	Ａｉｄｓ型疾患治療用組成物
JPH0618779B2 (ja) *	1986-01-22	1994-03-16	中外製薬株式会社	造血機能回復促進剤
GR871067B (en) *	1986-07-18	1987-11-19	Chugai Pharmaceutical Co Ltd	Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
CA1329119C (en) *	1988-03-29	1994-05-03	Milton David Goldenberg	Cytotoxic therapy
DE69001686T2 (de) *	1989-01-30	1993-09-02	Schering Corp	Behandlung von leukozytstoerungen mit gm-csf.
WO1992011022A1 (fr) *	1990-12-25	1992-07-09	Kyowa Hakko Kogyo Co., Ltd.	Preparation pharmaceutique destinee a une administration par voie nasale
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5686578A (en)	1994-08-05	1997-11-11	Immunomedics, Inc.	Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
EP2213743A1 (de)	2000-04-12	2010-08-04	Human Genome Sciences, Inc.	Albuminfusionsproteine
US8435939B2 (en)	2000-09-05	2013-05-07	Biokine Therapeutics Ltd.	Polypeptide anti-HIV agent containing the same
WO2005003296A2 (en)	2003-01-22	2005-01-13	Human Genome Sciences, Inc.	Albumin fusion proteins
AU2002364586A1 (en)	2001-12-21	2003-07-30	Delta Biotechnology Limited	Albumin fusion proteins
SI21273A (sl) *	2002-07-31	2004-02-29	LEK farmacevtska dru�ba d.d.	Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
AU2003261723A1 (en)	2002-08-27	2004-03-19	Takeda Chemical Industries, Ltd.	Cxcr4 antagonist and use thereof
KR100638453B1 (ko) *	2004-11-19	2006-10-24	씨제이 주식회사	포장용 박스 및 포장용 박스 접는방법
WO2008075371A2 (en)	2006-12-21	2008-06-26	Biokine Therapeutics Ltd.	T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
US9155780B2 (en)	2009-02-11	2015-10-13	Yeda Research And Development Co. Ltd.	Short beta-defensin-derived peptides
BRPI1009663A2 (pt)	2009-06-14	2016-10-11	Biokine Therapeutics Ltd	"método para elevação dos níveis plaquetários em um indivíduo com essa necessidade, método de inibição de hemorragia em um indivíduo que a necessite e composição farmacêutica"
EP2841084B1 (de)	2012-04-24	2018-05-30	Biokine Therapeutics Ltd.	Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
US10786547B2 (en)	2015-07-16	2020-09-29	Biokine Therapeutics Ltd.	Compositions, articles of manufacture and methods for treating cancer
KR102033920B1 (ko)	2016-02-23	2019-10-18	바이오라인알엑스 리미티드	급성 골수성 백혈병을 치료하는 방법
CN112175906B (zh) *	2019-07-05	2023-09-29	中国科学院生物物理研究所	胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6030295B2 (ja) *	1977-03-29	1985-07-16	森永乳業株式会社	白血球減少症治療剤の製造法
AU523077B2 (en) *	1978-03-20	1982-07-08	Green Cross Corporation, The	Hgi glycoprotein
JPS6030291B2 (ja) *	1978-03-20	1985-07-16	森永乳業株式会社	人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS5618591A (en) *	1979-07-20	1981-02-21	Morinaga Milk Ind Co Ltd	Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JPS6030654B2 (ja) *	1980-12-31	1985-07-17	株式会社林原生物化学研究所	ヒトコロニ−刺激因子の製造方法
AU594014B2 (en) *	1984-03-21	1990-03-01	Research Corporation Technologies, Inc.	Recombinant DNA molecules
JPS61227526A (ja) *	1984-07-25	1986-10-09	Chugai Pharmaceut Co Ltd	新規なコロニー刺激因子
JPS6181781A (ja) *	1984-09-28	1986-04-25	Morinaga Milk Ind Co Ltd	人顆粒球系前駆細胞の分化・増殖因子産生細胞および人顆粒球系前駆細胞の分化・増殖因子の製造法
JP3038348B2 (ja) *	1984-11-20	2000-05-08	シェーリングコーポレイション	ヒト顆粒状、マクロファージおよび好酸球の細胞増殖因子活性を示すポリペプチドをコードするｃＤＮＡクローン
JP2512453B2 (ja) *	1985-02-05	1996-07-03	シ−タスコ−ポレ−シヨン	天然のコロニ−促進因子―１の精製
JPH0615477B2 (ja) *	1985-02-08	1994-03-02	中外製薬株式会社	感染防禦剤
ATE65798T1 (de) *	1985-02-08	1991-08-15	Chugai Pharmaceutical Co Ltd	Menschlicher granuloxcyt-koloniestimulierungsfaktor.
JPS63500636A (ja) *	1985-08-23	1988-03-10	麒麟麦酒株式会社	多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
DE3681551D1 (de) *	1985-09-30	1991-10-24	Chugai Pharmaceutical Co Ltd	Menschlicher granulozyten-colony stimulierender faktor.
JPS6444200A (en) *	1987-08-12	1989-02-16	Kenji Hoshino	Stereophonic sound field recording and reproducing system
JPH0615477A (ja) *	1992-07-02	1994-01-25	Tanaka Kikinzoku Kogyo Kk	Ａｇろう

1986
- 1986-06-02 JP JP61125660A patent/JPH0618778B2/ja not_active Expired - Lifetime
- 1986-09-24 AU AU63121/86A patent/AU596997C/en not_active Expired
- 1986-10-01 FI FI863971A patent/FI863971L/fi not_active Application Discontinuation
- 1986-10-02 NO NO863918A patent/NO863918L/no unknown
- 1986-10-02 DK DK471386A patent/DK172204B1/da not_active IP Right Cessation
- 1986-10-02 KR KR1019860008292A patent/KR960000394B1/ko not_active Expired - Lifetime
- 1986-10-03 DE DE8686113671T patent/DE3683430D1/de not_active Expired - Lifetime
- 1986-10-03 ES ES86113671T patent/ES2055684T5/es not_active Expired - Lifetime
- 1986-10-03 EP EP86113671A patent/EP0217404B2/de not_active Expired - Lifetime
- 1986-10-03 AT AT86113671T patent/ATE71662T1/de not_active IP Right Cessation
1993
- 1993-07-08 HK HK656/93A patent/HK65693A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH0618778B2 (ja)	1994-03-16
FI863971A0 (fi)	1986-10-01
FI863971A7 (fi)	1987-04-05
NO863918L (no)	1987-04-06
EP0217404B2 (de)	1999-01-07
AU596997C (en)	1993-01-21
FI863971L (fi)	1987-04-05
AU6312186A (en)	1987-04-09
EP0217404A3 (en)	1988-07-13
DK471386A (da)	1987-04-05
EP0217404B1 (de)	1992-01-15
DK172204B1 (da)	1998-01-05
ES2055684T5 (es)	1999-06-16
DE3683430D1 (de)	1992-02-27
ES2055684T3 (es)	1994-09-01
DK471386D0 (da)	1986-10-02
NO863918D0 (no)	1986-10-02
KR870003792A (ko)	1987-05-04
KR960000394B1 (ko)	1996-01-06
EP0217404A2 (de)	1987-04-08
AU596997B2 (en)	1990-05-24
JPS62174026A (ja)	1987-07-30
HK65693A (en)	1993-07-16

Legal Events

Date	Code	Title
1992-09-15	UEP	Publication of translation of european patent specification
2000-04-15	UEP	Publication of translation of european patent specification
2007-01-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE71662T1 (de)	1992-02-15	Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.
DE3771509D1 (de)	1991-08-29	Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.
ATE74272T1 (de)	1992-04-15	Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
ATE65798T1 (de)	1991-08-15	Menschlicher granuloxcyt-koloniestimulierungsfaktor.
IL87621A0 (en)	1989-01-31	Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
NO952974D0 (no)	1995-07-27	G-CSF-analogpreparater og fremgangsmåter
ATE192500T1 (de)	2000-05-15	Rekombinante viren vektoren zur expression in muskelzellen
ATE67517T1 (de)	1991-10-15	Menschlicher granulozyten-colony stimulierender faktor.
ATE103494T1 (de)	1994-04-15	Verwendung von interleukin 2 zur behandlung von leukaemien.
EP0228018A3 (en)	1987-12-02	Gm-csf protein, its derivatives, preparation of such proteins and their use
ATE145556T1 (de)	1996-12-15	Verwendung von interleukin-4 zur behandlung der festen tumoren
DE59610632D1 (de)	2003-09-04	Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE320270T1 (de)	2006-04-15	Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DK12990A (da)	1990-03-16	Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
IL90391A0 (en)	1990-01-18	Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
EP0248583A3 (en)	1989-10-18	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE145939T1 (de)	1996-12-15	Mitogen für die glatte muskulatur und dessen kodierende dns
ATE65404T1 (de)	1991-08-15	Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis- faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.